(Q39367433)

11 September 2017

title

Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy (English)

1 reference

11 September 2017

main subject

Machado-Joseph disease

1 reference

1 reference

C-S Liu

1

1 reference

11 September 2017

H-M Hsu

series ordinal

2

1 reference

11 September 2017

W-L Cheng

series ordinal

3

1 reference

11 September 2017

M Hsieh

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Acta Neurologica Scandinavica

11 September 2017

published in

1 reference

11 September 2017

volume

111

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

385-390

1 reference

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Glutamine repeats and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Down-regulation of heat shock protein 27 in neuronal cells and non-neuronal cells expressing mutant ataxin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00405.X

10.1111/J.1600-0404.2005.00405.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference